Yung Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yung Lee has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
- Tyler McKechnie
Department of Surgery, McMaster University, Hamilton, Ontario, Canada
13 shared publications - Aristithes G. Doumouras
McMaster University
12 shared publications Dennis Hong
Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Canada
12 shared publications- Cagla Eskicioglu
Division of General Surgery, Department of Surgery McMaster University Hamilton Ontario Canada
11 shared publications - Dennis Hong
Division of General Surgery, McMaster University, Hamilton, Canada
8 shared publications Aristithes G. Doumouras
Division of General Surgery, Department of Surgery McMaster University Hamilton Ontario Canada
4 shared publications
Latest Publications
- 15 October 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-24
The patient perspective in benign foregut surgery guidelines: bridging evidence, values, and clinical decision-making
Background Patient values influence preference-sensitive decisions in benign foregut (upper gastrointestinal) surgery, but their incorporation into guideline development is unclear. This systematic review evaluated how patient perspectives are included in clinical practice guidelines (CPGs) and whether involvement is associated with quality. Methods Databases and society websites were searched for CPGs addressing endoscopic or surgical management of benign foregut disease from January 2010 to March 2026. Two reviewers screened records, extracted data, mapped involvement across the 10-stage Armstrong framework, and assessed quality using AGREE II. Results Twenty-six CPGs were included. All used evidence-grading methods, but only 8 (31%) reported direct patient involvement. Six additional CPGs (23%) considered patient values indirectly through literature review and clinician assumptions. No CPG published before 2018 reported direct involvement. Among patient-involved CPGs, engagement most often occurred during recommendation development (8/8), evidence interpretation (5/8), and question or outcome formulation (5/8). None reported patient involvement in dissemination, implementation, updating, or evaluation of engagement. Later publication year was associated with direct involvement (OR 1.54 per year). In unadjusted analyses patient-involved CPGs had higher AGREE II scores for clarity, applicability, and editorial independence, but this did not remain statistically significant in sensitivity analyses restricting publication year and methodologist involvement. Conclusions Direct patient involvement remains uncommon and concentrated in recommendation development rather than the entirety of guideline development. Foregut-related surgical societies should combine patient-preference evidence with transparently reported patient partnership from priority setting through implementation and updating. Graphical abstract
- 15 October 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-24
The patient perspective in benign foregut surgery guidelines: bridging evidence, values, and clinical decision-making
Background Patient values influence preference-sensitive decisions in benign foregut (upper gastrointestinal) surgery, but their incorporation into guideline development is unclear. This systematic review evaluated how patient perspectives are included in clinical practice guidelines (CPGs) and whether involvement is associated with quality. Methods Databases and society websites were searched for CPGs addressing endoscopic or surgical management of benign foregut disease from January 2010 to March 2026. Two reviewers screened records, extracted data, mapped involvement across the 10-stage Armstrong framework, and assessed quality using AGREE II. Results Twenty-six CPGs were included. All used evidence-grading methods, but only 8 (31%) reported direct patient involvement. Six additional CPGs (23%) considered patient values indirectly through literature review and clinician assumptions. No CPG published before 2018 reported direct involvement. Among patient-involved CPGs, engagement most often occurred during recommendation development (8/8), evidence interpretation (5/8), and question or outcome formulation (5/8). None reported patient involvement in dissemination, implementation, updating, or evaluation of engagement. Later publication year was associated with direct involvement (OR 1.54 per year). In unadjusted analyses patient-involved CPGs had higher AGREE II scores for clarity, applicability, and editorial independence, but this did not remain statistically significant in sensitivity analyses restricting publication year and methodologist involvement. Conclusions Direct patient involvement remains uncommon and concentrated in recommendation development rather than the entirety of guideline development. Foregut-related surgical societies should combine patient-preference evidence with transparently reported patient partnership from priority setting through implementation and updating. Graphical abstract
- Open Access
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1086-E1087
Completely endoscopic reversal of vertical banded gastroplasty using magnetic compression gastro-gastric anastomosis
- 1 October 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 05) , E1086-E1087
Open AccessCompletely endoscopic reversal of vertical banded gastroplasty using magnetic compression gastro-gastric anastomosis
- Open Access
- 1 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 7234-7242
A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation
Background and aims: Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal neoplasia but remains technically demanding because of limited traction, lack of triangulation, and high operator workload, contributing to a steep learning curve. We evaluated a novel endoluminal robotic platform designed to provide surgical-like bimanual triangulation, stable traction/counter-traction, and improved ergonomics while preserving compatibility with standard gastroscopes. Methods: The robotic system (Intilume System, Agilis Robotics, Hong Kong, SAR) uses an external positioning cart to drive two 3.5-mm flexible robotic instruments mounted onto a native gastroscope via a cap-and-sheath interface and controlled by compact pen-style motion-tracking controllers enabling seated operation. Available instruments included a bipolar T-knife and a tissue grasper. In a randomized crossover ex vivo porcine stomach study, two gastroenterology fellows without prior ESD experience and two interventional endoscopy fellows with early experience each performed four ESDs (two robotic, two conventional), for a total of 16 procedures. Outcomes included en bloc resection, procedure time, specimen surface area, dissection speed, tissue injury, and operator workload assessed using NASA-TLX, with exploratory OSATS and GEARS evaluations. Results: All procedures were completed (8 robotic, 8 conventional). Robotic ESD achieved 100% en bloc resection versus 75% with conventional ESD ( p = 0.47), was significantly faster (14.1 ± 4.3 vs 21.6 ± 7.6 min; p = 0.028), and demonstrated higher dissection speed (36.5 ± 23.4 vs 16.3 ± 10.1 mm 2 /min; p = 0.05). No muscular injuries occurred with robotic ESD compared with 5/8 conventional cases; no full-thickness injuries occurred. Operator workload was markedly lower with robotic ESD (NASA-TLX 34.7 ± 24.1 vs 75.0 ± 15.4; p = 0.002). Conclusion: In a randomized ex vivo model, a bimanual endoluminal robotic platform compatible with standard endoscopes demonstrated promising improvements in ESD efficiency, tissue control, and operator ergonomics compared with conventional ESD. These preliminary findings support further development and progression to first-in-human feasibility evaluation, with potential to facilitate ESD skill acquisition pending clinical validation.
- 1 July 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 7234-7242
Open AccessA novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation
Background and aims: Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal neoplasia but remains technically demanding because of limited traction, lack of triangulation, and high operator workload, contributing to a steep learning curve. We evaluated a novel endoluminal robotic platform designed to provide surgical-like bimanual triangulation, stable traction/counter-traction, and improved ergonomics while preserving compatibility with standard gastroscopes. Methods: The robotic system (Intilume System, Agilis Robotics, Hong Kong, SAR) uses an external positioning cart to drive two 3.5-mm flexible robotic instruments mounted onto a native gastroscope via a cap-and-sheath interface and controlled by compact pen-style motion-tracking controllers enabling seated operation. Available instruments included a bipolar T-knife and a tissue grasper. In a randomized crossover ex vivo porcine stomach study, two gastroenterology fellows without prior ESD experience and two interventional endoscopy fellows with early experience each performed four ESDs (two robotic, two conventional), for a total of 16 procedures. Outcomes included en bloc resection, procedure time, specimen surface area, dissection speed, tissue injury, and operator workload assessed using NASA-TLX, with exploratory OSATS and GEARS evaluations. Results: All procedures were completed (8 robotic, 8 conventional). Robotic ESD achieved 100% en bloc resection versus 75% with conventional ESD ( p = 0.47), was significantly faster (14.1 ± 4.3 vs 21.6 ± 7.6 min; p = 0.028), and demonstrated higher dissection speed (36.5 ± 23.4 vs 16.3 ± 10.1 mm 2 /min; p = 0.05). No muscular injuries occurred with robotic ESD compared with 5/8 conventional cases; no full-thickness injuries occurred. Operator workload was markedly lower with robotic ESD (NASA-TLX 34.7 ± 24.1 vs 75.0 ± 15.4; p = 0.002). Conclusion: In a randomized ex vivo model, a bimanual endoluminal robotic platform compatible with standard endoscopes demonstrated promising improvements in ESD efficiency, tissue control, and operator ergonomics compared with conventional ESD. These preliminary findings support further development and progression to first-in-human feasibility evaluation, with potential to facilitate ESD skill acquisition pending clinical validation.
- 29 June 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (8)
The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities
Introduction: The gut microbiome is a fundamental determinant of gastrointestinal physiology. It is essential in maintaining host homeostasis while also implicated in cancer pathogenesis and alteration in physiological response to surgical stress. This narrative review evaluates the microbiome's mechanistic role in surgical oncology, assessing it as a biomarker for risk stratification and an emerging therapeutic target. Method: The current literature was synthesized to examine microbial impacts on tumourigenesis and perioperative surgical outcomes across the lower and upper gastrointestinal tracts (including the gut-lung axis), the hepatopancreatobiliary system, and extra-abdominal malignancies (breast cancer and melanoma). Results: Dysbiotic microbial signatures, termed the oncobiome, actively drive tumour progression and immune evasion. Perioperative interventions induce acute microbial shifts linked to serious complications such as anastomotic leaks and pneumonia. Clinically, targeted modulation yields significant benefits as demonstrated by: perioperative synbiotics reducing infectious complications by 45% in colorectal surgery and 64% in major liver surgery. Furthermore, preoperative oral care reduces post-esophagectomy pneumonia by up to 50%, while Helicobacter pylori eradication halves metachronous gastric cancer risk. However, a detrimental “antibiotic paradox” exists in melanoma, where pre-treatment antibiotic exposure severely impairs immune checkpoint inhibitor efficacy. Conversely, faecal microbiota transplantation can reverse this immunotherapy resistance, achieving up to 80% response rates in trials. Conclusion: The microbiome is a critical, modifiable determinant of both short-term surgical recovery and long-term oncologic survival. Future surgical oncology practice will need to integrate precision surgical microbiome-mediated biotherapeutics to optimise outcomes in multidisciplinary cancer care.
- 29 June 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (8)
The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities
Introduction: The gut microbiome is a fundamental determinant of gastrointestinal physiology. It is essential in maintaining host homeostasis while also implicated in cancer pathogenesis and alteration in physiological response to surgical stress. This narrative review evaluates the microbiome's mechanistic role in surgical oncology, assessing it as a biomarker for risk stratification and an emerging therapeutic target. Method: The current literature was synthesized to examine microbial impacts on tumourigenesis and perioperative surgical outcomes across the lower and upper gastrointestinal tracts (including the gut-lung axis), the hepatopancreatobiliary system, and extra-abdominal malignancies (breast cancer and melanoma). Results: Dysbiotic microbial signatures, termed the oncobiome, actively drive tumour progression and immune evasion. Perioperative interventions induce acute microbial shifts linked to serious complications such as anastomotic leaks and pneumonia. Clinically, targeted modulation yields significant benefits as demonstrated by: perioperative synbiotics reducing infectious complications by 45% in colorectal surgery and 64% in major liver surgery. Furthermore, preoperative oral care reduces post-esophagectomy pneumonia by up to 50%, while Helicobacter pylori eradication halves metachronous gastric cancer risk. However, a detrimental “antibiotic paradox” exists in melanoma, where pre-treatment antibiotic exposure severely impairs immune checkpoint inhibitor efficacy. Conversely, faecal microbiota transplantation can reverse this immunotherapy resistance, achieving up to 80% response rates in trials. Conclusion: The microbiome is a critical, modifiable determinant of both short-term surgical recovery and long-term oncologic survival. Future surgical oncology practice will need to integrate precision surgical microbiome-mediated biotherapeutics to optimise outcomes in multidisciplinary cancer care.
- Open Access
- 26 May 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (9) , 13886-13894
Financial toxicity of general surgical emergencies in the United States: a nationwide retrospective cohort study
Background: Emergency general surgery (EGS) accounts for approximately 11% of all annual hospitalizations in the United States (U.S.) and represents a particularly vulnerable patient population. Termed “financial toxicity,” unexpected surgical admissions can result in significant financial hardship, which is associated with lower quality of life, severe psychological distress, and poor health outcomes. This study aimed to investigate the risk of financial toxicity among patients requiring admission for common EGS pathologies. Methods: All privately insured and uninsured patients who were admitted for the top five most common EGS conditions (biliary disease, appendicitis, diverticulitis, small bowel obstruction, and inguinal hernia) were identified from the National Inpatient Sample database from 2015 to 2019 using the International Classification of Diseases, 10th Revision, Diagnostic and Clinical Modification procedure codes. The risk of financial toxicity was defined as hospital expenditure greater than 40% of post-subsistence income. Results: Out of the 136 431 EGS admissions identified, 82% were privately insured, and 18% were uninsured. The overall median admission cost for EGS admission was $11 660 USD (interquartile range: $8505–$17 233). Approximately 47.6% (95% CI: 46.9%–48.2%) of uninsured patients and 0% of privately insured patients were at risk of catastrophic expenditure. Predictors of financial toxicity included male sex, younger age (18–39 years), Black or Hispanic race, low residential income, greater comorbidities, and treatment at a rural or non-teaching hospital. Conclusion: Approximately half of uninsured EGS patients were at risk of financial toxicity. Targeted financial protection interventions for those at risk of financial toxicity are needed.
- 26 May 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (9) , 13886-13894
Open AccessFinancial toxicity of general surgical emergencies in the United States: a nationwide retrospective cohort study
Background: Emergency general surgery (EGS) accounts for approximately 11% of all annual hospitalizations in the United States (U.S.) and represents a particularly vulnerable patient population. Termed “financial toxicity,” unexpected surgical admissions can result in significant financial hardship, which is associated with lower quality of life, severe psychological distress, and poor health outcomes. This study aimed to investigate the risk of financial toxicity among patients requiring admission for common EGS pathologies. Methods: All privately insured and uninsured patients who were admitted for the top five most common EGS conditions (biliary disease, appendicitis, diverticulitis, small bowel obstruction, and inguinal hernia) were identified from the National Inpatient Sample database from 2015 to 2019 using the International Classification of Diseases, 10th Revision, Diagnostic and Clinical Modification procedure codes. The risk of financial toxicity was defined as hospital expenditure greater than 40% of post-subsistence income. Results: Out of the 136 431 EGS admissions identified, 82% were privately insured, and 18% were uninsured. The overall median admission cost for EGS admission was $11 660 USD (interquartile range: $8505–$17 233). Approximately 47.6% (95% CI: 46.9%–48.2%) of uninsured patients and 0% of privately insured patients were at risk of catastrophic expenditure. Predictors of financial toxicity included male sex, younger age (18–39 years), Black or Hispanic race, low residential income, greater comorbidities, and treatment at a rural or non-teaching hospital. Conclusion: Approximately half of uninsured EGS patients were at risk of financial toxicity. Targeted financial protection interventions for those at risk of financial toxicity are needed.
- Open Access
- 8 May 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Applications of artificial intelligence along the perioperative pathway in metabolic and bariatric surgery
- 8 May 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Open AccessApplications of artificial intelligence along the perioperative pathway in metabolic and bariatric surgery
- Open Access
- 27 April 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (5)
Modern treatment for achalasia: endoscopic and surgical therapies
Achalasia is a rare, progressive oesophageal motility disorder defined by impaired lower oesophageal sphincter relaxation and absent peristalsis, leading to dysphagia, regurgitation, chest pain, weight loss, and increased long-term risks of aspiration and malignancy. Management has evolved from open surgical myotomy to minimally invasive laparoscopic and robotic techniques and, more recently, peroral endoscopic myotomy (POEM). This review summarizes contemporary diagnostic strategies, including high-resolution manometry, timed barium oesophagram, endoscopy, and emerging applications of impedance planimetry, and critically appraises current endoscopic and surgical therapies. The review compares outcomes of pneumatic dilation, botulinum toxin injection, minimally invasive Heller myotomy with fundoplication, POEM, POEM with fundoplication, and newer approaches for advanced disease such as peroral oesophageal plication and oesophagectomy, integrating data from randomized trials and long-term cohort studies. Key issues, including post-treatment gastro-oesophageal reflux, cancer surveillance, and management of recurrent or refractory symptoms, are addressed. Treatment selection is emphasized as individualized, incorporating manometric subtype, oesophageal morphology, patient co-morbidity, institutional expertise, procedural durability, complication profiles, and evolving guideline recommendations across international expert consensus groups. Contemporary multimodal therapy enables durable symptom control and meaningful quality-of-life improvement for most patients, while ongoing innovation and longer-term follow-up will continue to refine treatment algorithms and standards of care.
- 27 April 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (5)
Open AccessModern treatment for achalasia: endoscopic and surgical therapies
Achalasia is a rare, progressive oesophageal motility disorder defined by impaired lower oesophageal sphincter relaxation and absent peristalsis, leading to dysphagia, regurgitation, chest pain, weight loss, and increased long-term risks of aspiration and malignancy. Management has evolved from open surgical myotomy to minimally invasive laparoscopic and robotic techniques and, more recently, peroral endoscopic myotomy (POEM). This review summarizes contemporary diagnostic strategies, including high-resolution manometry, timed barium oesophagram, endoscopy, and emerging applications of impedance planimetry, and critically appraises current endoscopic and surgical therapies. The review compares outcomes of pneumatic dilation, botulinum toxin injection, minimally invasive Heller myotomy with fundoplication, POEM, POEM with fundoplication, and newer approaches for advanced disease such as peroral oesophageal plication and oesophagectomy, integrating data from randomized trials and long-term cohort studies. Key issues, including post-treatment gastro-oesophageal reflux, cancer surveillance, and management of recurrent or refractory symptoms, are addressed. Treatment selection is emphasized as individualized, incorporating manometric subtype, oesophageal morphology, patient co-morbidity, institutional expertise, procedural durability, complication profiles, and evolving guideline recommendations across international expert consensus groups. Contemporary multimodal therapy enables durable symptom control and meaningful quality-of-life improvement for most patients, while ongoing innovation and longer-term follow-up will continue to refine treatment algorithms and standards of care.
- 8 April 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (5) , 2611-2624
Efficacy and Safety of Tranexamic Acid Use in Bariatric Surgery: An Updated Systematic Review and Meta-Analysis
- 8 April 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (5) , 2611-2624
Efficacy and Safety of Tranexamic Acid Use in Bariatric Surgery: An Updated Systematic Review and Meta-Analysis
- 16 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1397-1405
IFSO Survey: Use of Large Language Models (LLMs) by Metabolic Bariatric Surgeons and Integrated Health Professionals
- 16 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1397-1405
IFSO Survey: Use of Large Language Models (LLMs) by Metabolic Bariatric Surgeons and Integrated Health Professionals